Advancements in cancer treatment have opened new doors for patients, providing more effective and tailored options. While traditional methods like surgery, chemotherapy, and radiation continue to play a crucial role, newer approaches are gaining ground. Targeted therapies focus on disrupting the specific molecular pathways that drive cancer growth, while immunotherapies harness the body’s immune system to better target cancer cells. Additionally, personalized medicine is revolutionizing treatment by customizing therapies based on the patient’s genetic makeup. Together, these innovations are transforming cancer care, offering greater hope for improved survival rates and quality of life.
Title : The role of artificial intelligence (AI) in oncology
Marika Crohns, Impactful Innovations Management Consultants LLC, United Arab Emirates
Title : Principles of oral rehabilitation in H&N cancer patients
Pietro Salvatori, Independent H&N Surgeon, Italy
Title : Molecular-genetic study of low-grade and high-grade “basal-like” (triple-negative) breast carcinomas
Farid Moinfar, Ordensklinikum Linz Barmherzige Schwestern, Austria
Title : The future of pharmacogenetic polymorphism, pharmacogenomics and pharmamicrobiome in cancer treatment
Bene Ekine-Afolabi, University of East London, United Kingdom
Title : Altered expression of endoplasmic reticulum stress response genes and circular RNAs in oral squamous cell carcinoma tumorigenesis
Vandana Tiwari, Dr. Ram Manohar Lohia Institute of Medical Sciences, India
Title : Targeting noncanonical epitopes in anti-cancer immunotherapy
Michele Mishto, Francis Crick Institute, United Kingdom